| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005009980A1 Substituted pyridin-2-ylamine analogues |
| 02/03/2005 | WO2005009978A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | WO2005009977A1 Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009479A1 Radiolabeled cannabinoid-1 receptor modulators |
| 02/03/2005 | WO2005009443A1 2-amino-4-hydroxy-5-pyrimidinecarboxamide derivatives and related compounds as inhibitors of t cell activation for the treatment of inflammatory diseases |
| 02/03/2005 | US20050027120 Method for the synthesis of amides and related products from esters or ester-like compounds |
| 02/03/2005 | US20050026914 Pyrimidine or pyridine carbamate compounds as for example 1,1-dimethylethyl 4-(4-((4-((((2,6-dimethylphenyl)oxy)carbonyl)(4-(methyloxy)phenyl)amino)-2-pyrimidinyl)amino)phenyl)-1-piperazinecarboxylate; for the treatment of protein tyrosine kinase-associated disorders |
| 02/03/2005 | US20050026785 Novel phenyl-propargylether derivatives |
| 02/03/2005 | US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 02/03/2005 | US20050025774 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS |
| 02/03/2005 | DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 02/03/2005 | CA2744317A1 Substituted tetracycline compounds |
| 02/03/2005 | CA2533397A1 Substituted pyridin-2-ylamine analogues |
| 02/03/2005 | CA2532980A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | CA2531490A1 Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2530087A1 Radiolabeled cannabinoid-1 receptor modulators |
| 02/03/2005 | CA2529734A1 2-amino-4-hydroxy-5-pyrimidine carboxamide derivatives and related compounds as inhibitors of t cell activation for the treatment of inflammatory diseases |
| 02/02/2005 | EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives |
| 02/02/2005 | EP1501898A1 Water-soluble fiber-reactive dyes, method for the production and use thereof |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501813A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1299389A4 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence |
| 02/02/2005 | EP1292591B1 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/02/2005 | EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/02/2005 | EP1184376B1 Novel heterocyclic carboxamide derivatives |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1572786A Uracil compounds and use thereof |
| 02/02/2005 | CN1572337A Health gauze mask |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187340C Uracil compound and its use |
| 02/02/2005 | CN1187339C Method for producing 4, 6-disubstituted 2-isocyanatopyrimidines and their use as intermediate products for active ingredient syntheses |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849732 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849634 Potassium channel inhibitors |
| 02/01/2005 | US6849618 Herbicidal compositions for the desiccation/ defoliation of plants |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 01/27/2005 | WO2005007672A2 Small molecule toll-like receptor (tlr) antagonists |
| 01/27/2005 | WO2005007647A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007633A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007165A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | WO2005007164A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | WO2005007124A2 Substituted dihydropyrimidine inhibitors of calcium channel function |
| 01/27/2005 | WO2005007092A2 Novel chemical compounds |
| 01/27/2005 | WO2004069794B1 New arylpiperazinyl compounds |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | WO2004064741A3 Compounds, compositions, and methods |
| 01/27/2005 | US20050020833 Reacting bromoalkyl-p-benzoic acid with triethyl phosphite; cyclization; reduction; anticancer agents; immunosuppressants; antiinflammatory agents |
| 01/27/2005 | US20050020648 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 01/27/2005 | US20050020612 4-Aryliquinazolines and the use thereof as nhe-3 inhibitors |
| 01/27/2005 | US20050020604 5-HT receptor ligands and uses thereof |
| 01/27/2005 | US20050020590 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020533 Ceramide analogs, process for their preparation and their use as antitumor agents |
| 01/27/2005 | US20050020505 Angiogenesis inhibitors; antitumor agents; anticancer agents; atherosclerosis; cardiovascular disorders; antiarthritic agents |
| 01/27/2005 | US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 01/27/2005 | CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | CA2531508A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | CA2531507A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | CA2528774A1 Small molecule toll-like receptor (tlr) antagonists |
| 01/26/2005 | EP1500652A1 Quinazoline derivative and medicine |
| 01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
| 01/26/2005 | EP1499609A2 Pesticidal heterocycles |
| 01/26/2005 | EP1499598A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1571773A Process for the preparation of (pyrimidin-2-yl)methyl ketones |
| 01/26/2005 | CN1569844A Slfonyl urea compounds and their production method and use |
| 01/26/2005 | CN1569843A Preparation method for sulfadoxine |
| 01/26/2005 | CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846830 Naphtalene derivatives and their pharmaceutical use |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/25/2005 | CA2191647C Process improvement in the synthesis of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| 01/25/2005 | CA2103383C Quinazoline derivatives |